We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.80 | 3.60 | 4.00 | 3.80 | 3.80 | 3.80 | 205,010 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 3.19M | -6.49M | -0.0122 | -3.11 | 20.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/9/2024 11:13 | Good at spending money on new hires Very bad at selling actual product | ravenna23 | |
23/9/2024 10:45 | Sept 23 24 I bought a starter position in this a few weeks ago using some of the proceeds of the PHC takeover. I would have preferred a stronger cash position which will be impacted by full year expenses of the three very sensible hires. I note the increase in Taxation as a current asset and hope this means that the £434k R&D received in H2 2023 will be higher this year. My reading of the Cavendish forecast is that they see a reduced H2 2024 cash burn of £1.2m. I need to work out why trade receivables and payables are so high compared to the levels of activity of the business. Fingers crossed that Cavendish forecast for H2 sales of £3.1m is accurate | cerrito | |
23/9/2024 10:06 | The tide is turning… about time. 2024 has been a pivotal year. 2025 will begin to get the rewards we have all been seeking (well apart from two muppet’s who infest this board). When the markets begin to wake up to what Eden has the share price will respond positively. | kittybiscuits | |
23/9/2024 09:51 | #Exponential. Looking that way (doubling every year) for product sales. | weyweyumfozo | |
23/9/2024 09:24 | That depends on how hard you look... If you look at all ..that is. Looks like Eden have the Greenlight for Go all around to me. #HugePotential. | supersonico | |
23/9/2024 09:17 | Reasons to be cheerful part 4Showing my age.Very few. | ravenna23 | |
23/9/2024 08:28 | Exactly : think through that question of yours. | alchemy | |
23/9/2024 08:21 | Alchemy23 Sep '24 - 07:43 - 18610 of 18611 Research tree note just arrived - one liner - huge potential. -------------------- When did it not? ;) | brucie5 | |
23/9/2024 08:21 | I was hoping for a 2 as the first number - nearly there. As Alchemy writes - only three months till year end - so Alex's guide that they will achieve the key financial metrics for the full year must be based upon good data. It won't be long till the 2025 projections are published - with product sales of £1.6m in 2021; £2.6m in 2023; expected £4.9m in 2024 - what do we expect for 2025? Personally I am expecting £10m with a decent profit and cash positive. Of course, the £10m could easily be kicked out the park if regulatory approvals come through for ecovelex, French approval for mevalone for downy and powdery mildew and or insecticide in the US. As someone wrote - the potential for Eden is huge. Sean wrote - some £2.3m has been spent upon product development in the last twelve months. Some may fear the Company may need to raise more cash - remember, the funds raised last year were to be spent on product development - and just look at the Company reports to see how broad and deep our products reach in tackling farmer's issues. Remember too, the Company is on a race to develop its IP as quickly as possible before a major comes along to acquire us. Anyhow, the Company is clearly not going to run out of cash - this morning's Cavendish update has cash at £3.7m at Dec 2024 with the GP rising to 67%. With the BoD expecting better performance in 2025 - I don't see us running out of cash when trading will be cash positive. It won't be long till the Market wakes up to the quality of Eden and how long it can remain independent. | attyg | |
23/9/2024 06:43 | Yes they've recruited - couldn't resist putting overheads up . I think we'll find out why..Research tree note just arrived - one liner - huge potential. | alchemy | |
23/9/2024 06:40 | Large increase in admin costs. Royalties. 500k increase in sales. Inventory levels unchanged (relatively). | timbo_slice | |
23/9/2024 06:36 | I never ever watch level 2 form up. But tea in hand .....,.... | alchemy | |
23/9/2024 06:26 | Ps. TAXI for Neuts! | money never sleeps | |
23/9/2024 06:24 | Only three months from statements about the full year if last year is a guide.Chairman is so positive. Urbane Dutch always top folks. | alchemy | |
23/9/2024 06:23 | That's good revenue growth. That's what I feared we might not see. 2025 already looks very promising - even more so if we get ecovelex approvals too | money never sleeps | |
23/9/2024 06:14 | That's the quote. Monets impression is mine too. | alchemy | |
23/9/2024 06:05 | Be in no doubt, the potential for Eden is huge. | monet | |
23/9/2024 05:22 | Poor Neuts. | timbo_slice | |
22/9/2024 21:48 | > PepsiCo Eh?? So Eden Research is switching to the non-alcoholic beverages biz? Guess they can't possibly do any worse than they've done as a pretend biotech! :D :D STOCKOPEDIA CLASSIFICATION: SUCKER Stock Our Target SP: ZERO PENCE (0.0000p) | neutralpov | |
22/9/2024 18:11 | PepsiCo aims to transform regenerative agriculture with over $6 million in grants — here's where the money will go The overarching priority is to "create the best outcome for the farmer, their land, their community, and the climate." | supersonico | |
22/9/2024 18:07 | Go on AttyG please tell me your hope for tomorrow's revenue announcement. It cannot do any harm. And I fully acknowledge that you are an uber bull! | money never sleeps | |
22/9/2024 14:45 | Hi AttyG I hope for better but I cannot help but think that pessimism is more realistic. It is Eden. It is AIM. Say no more! Monday is a nice day to bury BAD news too. On ecovelex, how much was pre-booked into 2023 figures compared to 2024? But if the sales are seen to be growing, surely the market will sit up and take notice ? | money never sleeps |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions